Stem cells may lead the way towards innovative treatments for eye disease. Hear from experts on the latest research.

Moderated by Dennis Clegg, PhD, UC Santa Barbara
Kristin MacDonald: Patient Perspective
Henry Klassen, MD, PhD, UCI: Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa
Theodore Leng, MD, MS, Stanford University: NeuBright, a purified allogeneic cell therapy product for treatment of Dry Age-related Macular Degeneration
Sophie Deng, MD, PhD, UCLA: Limbal stem cell therapy Recorded on 09/14/2020. (#36327)